Safety issues associated with proton pump inhibitors (PPIs) have recently attracted
widespread media and lay attention. Gastroenterologists are frequently asked about the …

First introduced in 1989, proton pump inhibitors (PPIs) are among the most widely utilized
medications worldwide, both in the ambulatory and inpatient clinical settings. The PPIs are …

Proton-pump inhibitors (PPIs) are a widely prescribed class of medications used to treat acid-
related disorders and use has significantly increased over the last few decades. PPIs are …

To identify the relationship between proton-pump inhibitors (PPIs) and the risk of fracture, we
conducted an update meta-analysis of observational studies. Results showed that PPI use …

Background Abnormal acid gastro-oesophageal reflux is common in patients with idiopathic
pulmonary fibrosis (IPF) and is considered a risk factor for development of IPF. Retrospective …

Purpose To describe the prevalence of, risk factors for, and prognostic importance of
gastrointestinal (GI) bleeding and use of acid suppressants in acutely ill adult intensive care …

Proton pump inhibitors (PPIs) are an antacid drug often used in acid-related disorders. They
decrease acid secretion in the stomach by blocking an enzyme called H+/K+ ATPase which …

Drugs that modify the risk of dementia in the elderly are of potential interest for dementia
prevention. Proton pump inhibitors (PPIs) are widely used to reduce gastric acid production …

Background Gastro-oesophageal reflux disease is a common chronic ailment that causes
uncomfortable symptoms and increases the risk of oesophageal adenocarcinoma. We …

We performed a meta-analysis of relevant studies to quantify the magnitude of the
association between proton pump inhibitors (PPIs) and risk of hip fracture. Patients with PPIs …